as declared in arstechnica
Trading in stock of medical device paused after hackers team with short seller
Trading in stock of medical device paused after hackers team with short sellerTrading in the stock of medical device manufacturer St. Jude Medical was halted Friday afternoon after a dramatic drop in its value.That drop was triggered by news of alleged vulnerabilities in the company's cardiac care devices.The vulnerability was disclosed not in a report by the company but by security researchers partnered with Muddy Waters Capital, an investment firm that had "shorted" St. Jude's stock on the information in order to profit from a drop in the stock's value.
additionally scmagazine
MedSec goes its own way with medical device flaw
MedSec goes its own way with medical device flawMedSec goes its own way with medical device flawShare this content:linkedingooglePrintMedSec is claiming that heart devices produced by St. Jude's are vulnerable to cyberattack.In an arrangement that has raised both eyebrows and ethical ondisclosure questions among security pros, when cybersecurity firm MedSec detected a flaw in a medical device from St. Jude Medical, it eschewed seeking a bug bounty from the manufacturer for the find and instead partnered with an investment firm to capitalize on its knowledge and short sell stock in the device manufacturer.They won big on Thursday when the stock of the pacemaker manufacturer dropped sharply after their report broke that the implanted heart devices could be susceptible to cyberattacks, according to a Reuters story.
let alone csmonitor
Cybersecurity firm stirs controversy in alleging medical device flaws
Cybersecurity firm stirs controversy in alleging medical device flawsThe firm MedSec went to an investment advisory firm instead of medical device maker St. Jude to disclose potential security vulnerabilities.Zero-days: Why these security flaws are so dangerous and expensiveTicker and trading information for St. Jude Medical displayed on the floor of the New York Stock Exchange.In an apparent first, the investment firm Muddy Waters Capital on Thursday relied on cybersecurity research to recommend that investors bet against a major medical device maker's stock.
No comments:
Post a Comment